The siRNA targeted to <it>mdr1b </it>and <it>mdr1a </it>mRNAs <it>in vivo </it>sensitizes murine lymphosarcoma to chemotherapy
<p>Abstract</p> <p>Background</p> <p>One of the main obstacles for successful cancer polychemotherapy is multiple drug resistance phenotype (MDR) acquired by tumor cells. Currently, RNA interference represents a perspective strategy to overcome MDR via silencing the gen...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/204 |